Cybersecurity Scan — September 4, 2026 Close
Cybersecurity Scan — September 4, 2026 Close
The whole board gave back last scan's earnings-fueled bounce — PANW posted the board's worst week (-10.36%) despite beating Q4 estimates and announcing an acquisition (reported Sept 1-2), and ZS fell -7.99% on the week despite its own confirmed earnings beat and upbeat guidance (reported Sept 3). OKTA was the lone exception, holding onto most of last scan's gain (+2.62% week, still +16.02% on 30 days) after its own earnings beat two scans ago. BB dropped back into oversold on no confirmed catalyst.
Data as-of 2026-09-04 close. All numbers from precomputed summaries/cybersec.json. Prior scan: 2026-08-28-cybersec (2026-08-28, data as-of 2026-08-28 close) — the summary's own 7-day window runs 2026-08-28 to 2026-09-04, so the comparisons below line up exactly with that prior scan.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 A board-wide reversal of last scan's bounce, with two confirmed earnings beats (PANW, ZS) that didn't stop their stocks from falling this week — the same beat-but-sell pattern showed up elsewhere on the tape this session. |
| Key insight | ZS and PANW both reported real beats this week and both still posted the board's worst weekly declines (-7.99% and -10.36%) — a genuine disconnect between the confirmed fundamentals and the price action that isn't resolved by anything on file. |
What's Going On
PANW had the board's worst week: RSI fell from 55.8 to 43.5, price from $371.59 to $333.26, and the week dropped 10.36%. The news receipt on file (fetched 2026-09-04, fresh) shows a genuine beat — "Palo Alto Networks topped estimates as AI risks spur demand for its cybersecurity tools" and a Console acquisition to strengthen agentic capabilities, both reported Sept 1-2 — yet the stock fell harder than any other name on the board this week. PANW remains 43.0% above its 200-day average with a trailing year of +73.26% (alpha1y +54.61), so this reads as a sharp pullback inside a still-strongly-intact trend, not a break, but the disconnect between the confirmed beat and the price move isn't explained by anything captured this session.
ZS showed the same pattern at a smaller scale: RSI fell from 60.4 to 48.3, price from $184.23 to $169.80, week +1.29%→-7.99%. The news receipt (fetched Sept 4, fresh) confirms a Q4 earnings beat with upbeat guidance, reported Sept 3 — "Zscaler stock rises on earnings beat" per the headline — yet the stock closed the week down nearly 8%. ZS remains the board's one structurally weak name regardless: still 1.5% below its 200-day with a trailing year of -36.7% (alpha1y -55.35), a death-crossed name where the long trend is genuinely under test even before this week's beat-that-didn't-hold.
The rest of the board mostly reversed lower in step. FTNT's week flipped from +8.12% to -5.86% (RSI 57.2→47.8, 30-day flipping negative to -4.78% from +8.34%), CRWD cooled from its sharp reversal (RSI 58.2→53.1, week +13.8%→-2.44%, but the 30-day change stayed positive at +1.54%), NET's week flipped from +2.28% to -6.95% (30-day flipping negative to -4.79% from +10.90%), and S's week flipped from +1.84% to -7.71% (30-day flipping negative to -5.33% from +16.31%). HACK, BUG, and CIBR all reversed lower in the same pattern (30-day changes flipping negative across the board). BB dropped back into oversold — RSI 44.1→39.3, price $8.16→$7.70, week +1.49%→-5.64%, 30-day flipping to -11.8% from +4.48% — on a news receipt that's stale (fetched Aug 27, before this week's window) and unrelated to a price catalyst.
OKTA was the exception: RSI eased only slightly (64.7→63.4), price rose from $166.23 to $170.60, and the week normalized to +2.62% from +22.91% rather than reversing outright — the 30-day change stayed strong at +16.02%. OKTA's earnings-beat catalyst from two scans ago is still holding up better than any other name's this week.
What Changed Since Prior Scan (2026-08-28 close → 2026-09-04 close)
- PANW posted the board's worst week despite a confirmed beat and acquisition: RSI 55.8→43.5, price $371.59→$333.26, 7D +3.88%→-10.36%, 30D +18.28%→-8.11%.
- ZS fell despite a confirmed earnings beat and upbeat guidance: RSI 60.4→48.3, price $184.23→$169.80, 7D +1.29%→-7.99%, 30D +19.81%→+5.04%.
- FTNT's 30-day window flipped negative: RSI 57.2→47.8, price $166.00→$156.29, 7D +8.12%→-5.86%, 30D +8.34%→-4.78%.
- NET's 30-day window flipped negative: RSI 54.3→46.7, price $299.84→$278.92, 7D +2.28%→-6.95%, 30D +10.90%→-4.79%.
- S's 30-day window flipped negative: RSI 54.3→45.7, price $21.54→$19.88, 7D +1.84%→-7.71%, 30D +16.31%→-5.33%.
- BB dropped back into oversold: RSI 44.1→39.3, price $8.16→$7.70, 7D +1.49%→-5.64%, 30D +4.48%→-11.8%.
- CRWD cooled but stayed positive on the month: RSI 58.2→53.1, price $218.40→$213.10, 7D +13.8%→-2.44%, 30D 21.75%→+1.54%.
- HACK, BUG, CIBR all reversed lower in step: HACK RSI 55.5→48.0, BUG 58.1→51.1, CIBR 57.0→48.4; 30-day changes all flipped negative.
- OKTA held up best on the board: RSI 64.7→63.4, price $166.23→$170.60, 7D +22.91%→+2.62%, 30D +21.42%→+16.02%.
How To Read The Board
Every name except ZS carries a golden cross. This scan is the mirror image of last one — nearly every name gave back its bounce, and two of the reversals (PANW, ZS) came with confirmed earnings beats attached, not absent catalysts. On the long-horizon test: FTNT, PANW, CRWD, OKTA, HACK, BUG, and CIBR all remain comfortably above their 200-day with trailing-year returns north of 30% (several well above 70%) — this week's declines are pullbacks inside strongly intact trends, not breaks. NET and S both sit above their 200-day with positive trailing-year returns as well, though less extreme. ZS remains the one name where the long trend is genuinely being tested — below its 200-day, negative on the year, and now showing that even a confirmed beat couldn't turn the week positive. BB's trailing year (+102.63%) and 200-day cushion (+28.6%) keep it in pullback territory rather than a break, but this week's drop into oversold has no catalyst on file.
Price Table
| Stock | Price | RSI | SMA20 | vs SMA | 7D% | 30D% | Signal |
|---|---|---|---|---|---|---|---|
| OKTA | $170.60 | 63.4 | $151.36 | +12.7% | +2.62% | +16.02% | 🟡 Neutral |
| CRWD | $213.10 | 53.1 | $210.56 | +1.2% | -2.44% | +1.54% | 🟡 Neutral |
| ZS | $169.80 | 48.3 | $179.46 | -5.4% | -7.99% | +5.04% | 🟡 Neutral |
| HACK | $110.75 | 48.0 | $114.17 | -3.0% | -4.14% | -3.4% | 🟡 Neutral |
| CIBR | $94.59 | 48.4 | $97.01 | -2.5% | -3.98% | -3.05% | 🟡 Neutral |
| NET | $278.92 | 46.7 | $296.28 | -5.9% | -6.95% | -4.79% | 🟡 Neutral |
| S | $19.88 | 45.7 | $21.48 | -7.5% | -7.71% | -5.33% | 🟡 Neutral |
| FTNT | $156.29 | 47.8 | $159.27 | -1.9% | -5.86% | -4.78% | 🟡 Neutral |
| BUG | $41.37 | 51.1 | $41.87 | -1.2% | -3.57% | +0.34% | 🟡 Neutral |
| PANW | $333.26 | 43.5 | $363.78 | -8.4% | -10.36% | -8.11% | 🟡 Neutral |
| BB | $7.70 | 39.3 | $8.27 | -6.9% | -5.64% | -11.8% | 🟢 Oversold |
Tier Analysis
Capitulation (RSI<25): None.
Oversold (25-40): BB (39.3) — one name, newly falling in this scan.
Neutral/Strong (40+): The rest of the board, spanning PANW (43.5) to OKTA (63.4, the board's highest print).
Entry Zones
| Stock | Price | RSI | 30D% | Setup |
|---|---|---|---|---|
| PANW | $333.26 | 43.5 | -8.11% | Board's worst week despite a confirmed beat and acquisition announcement; still 43.0% above its 200-day with a +73.26% trailing year — an intact trend under a sharp, unexplained pullback |
| ZS | $169.80 | 48.3 | +5.04% | Confirmed earnings beat and upbeat guidance (Sept 3) didn't stop a -7.99% week; still the board's one structurally weak name — below its 200-day with a negative trailing year |
| OKTA | $170.60 | 63.4 | +16.02% | Held up best on the board this scan; still riding a confirmed earnings-beat catalyst from two scans ago |
| BB | $7.70 | 39.3 | -11.8% | Dropped back into oversold with no catalyst on file; still up 102.63% over the trailing year |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔍 WATCH | PANW | Board's worst week despite a confirmed beat and acquisition; confirm whether the pullback resolves or extends |
| 🔍 WATCH | ZS | Beat and raised guidance but still fell hard on the week; the one name where the long trend is genuinely under test |
| 🔒 HOLD | FTNT, CRWD, NET, S, HACK, BUG, CIBR | Pulled back this week inside strongly intact, well-above-200-day uptrends |
| 🔒 HOLD | OKTA | Held up best on the board; still riding a confirmed earnings catalyst |
| 🔍 WATCH | BB | Dropped back into oversold with no catalyst on file; confirm follow-through |
What To Watch Next
| Watch | Why it matters |
|---|---|
| Whether PANW's pullback resolves | Board's worst week this scan despite a confirmed beat and acquisition news |
| ZS's 200-day level | Genuinely testing its long trend even after a confirmed beat this week |
| Whether the board-wide reversal is a pause or a fuller unwind | Nearly every name gave back last scan's earnings-fueled bounce |
| BB's next session | Dropped back into oversold with no catalyst established |
| OKTA's continued outperformance | The one name that held up through this week's board-wide reversal |
Sources
- Tape data (price/RSI/SMA/returns/long-horizon): full-scan pre-computed summaries as of the 2026-09-04 close — cybersec.
- PANW news receipt checked (latest, fetched 2026-09-04, fresh): Q4 estimates beat and Console acquisition announced, reported 2026-09-01 and 2026-09-02.
- ZS news receipt checked (latest, fetched 2026-09-04, fresh): Q4 fiscal 2026 earnings beat with upbeat guidance, reported 2026-09-03.
- BB news receipt checked (latest, fetched 2026-08-27, before this week's window): no cause claimed for this week's drop into oversold.
Related
10 eventsNo direct external sources are attached to this read.